Timing of Therapies
Our predecessor site BCCT summarizes the evidence regarding the effects of timing of therapies with cancer.
. Last modified on : Feb 13 2024Statins
Our predecessor site BCCT summarizes the evidence regarding statins’ effects with cancer.
. Last modified on : Jun 21 2024Rapamycin (Sirolimus)
By blocking certain functions of the mTOR enzyme, rapamycin reduces cell growth. It therefore may be useful in treating or preventing proliferative diseases, including cancer.
. Last modified on : Feb 27 2023Propranolol and Other Beta Blockers
Our predecessor site BCCT summarizes the evidence regarding propranolol’s and other beta blockers’ effects with cancer.
. Last modified on : Jan 14 2024Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation, with notable benefits in increasing survival and reducing risk of several types of cancer; expert consensus is that the risks of harm from using these drugs long-term for prevention are greater than the benefits for many people.
. Last modified on : Dec 19 2023Metformin
Metformin, used to manage diabetes, may lower cancer risk and improve survival, mostly among people with diabetes or high blood sugar.
. Last modified on : Sep 27 2024Mebendazole or Fenbendazole
Mebendazole, a prescription drug used in humans to treat parasites, and fenbendazole, a treatment for parasites in animals, show promising but so far very preliminary evidence of anticancer effects.
. Last modified on : Sep 27 2024Low-dose Naltrexone
This prescription drug is used off-label in low doses to treat people with cancer, with notable but very preliminary successes in cases where the cancers were difficult-to-treat or quite advanced.
. Last modified on : Dec 20 2023Hyperthermia
Many types and varieties of hyperthermia (heat treatment) are used in conventional cancer care, and some additional uses are being explored for improving survival and reducing risk of recurrence.
. Last modified on : Apr 12 2024Copper Chelation
Copper promotes the formation of blood vessels, including those that supply tumors. Depleting copper can deprive the tumor of its suppliers.
. Last modified on : Jan 14 2024